Welcome to our dedicated page for Avantor news (Ticker: AVTR), a resource for investors and traders seeking the latest updates and insights on Avantor stock.
Avantor, Inc. reports developments as a life science tools company supplying mission-critical products and services to life sciences and advanced technology customers through its VWR Distribution & Services and Bioscience & Medtech Products businesses. Recurring updates cover earnings, cash flow, leverage, guidance, segment performance and the company’s Revival transformation program, including VWR brand activity, manufacturing and supply-chain improvements and e-commerce upgrades.
Company news also covers portfolio and infrastructure actions such as Masterflex fluid handling systems, single-use assemblies, peristaltic pumps, J.T. Baker high-purity process chemicals, and expanded microbial and stability testing capabilities for regulated biopharma manufacturing. Governance and management updates include finance leadership changes and appointments tied to bioscience, medtech products and enterprise transformation.
Avantor (NYSE: AVTR) will engage in a virtual fireside chat at the Raymond James 42nd Annual Institutional Investor Conference on March 1, 2021, starting at 4:40 p.m. Eastern Time. Michael Stubblefield, President and CEO, will represent the company. Investors can access the live webcast via Avantor's investor relations page, with a replay available until March 31, 2021. Avantor is a leading provider of mission-critical products and services across biopharma, healthcare, and advanced technologies, serving over 225,000 customer locations in 180 countries.
Avantor, Inc. (NYSE: AVTR) announced a significant upgrade in its credit rating to 'BB+' with a stable outlook by S&P Global Ratings on February 10, 2021. The company's CFO, Thomas Szlosek, expressed satisfaction with this acknowledgment, highlighting their strong operational performance amidst a challenging market environment. Avantor's integrated business model has been crucial in supporting customers across various research phases. The company serves over 225,000 customer locations globally, underscoring its extensive reach and infrastructure in the life sciences and advanced technologies sectors.
Avantor, Inc. (NYSE: AVTR) reported strong financial results for Q4 and the full year 2020, showcasing resilience in a challenging environment. Q4 net sales reached $1.791 billion, up 17.5% YoY, with organic growth of 14.9%. The company generated $286 million in free cash flow. For the full year, net sales were $6.394 billion, marking a 5.8% increase, and free cash flow surged 187% to $868.2 million. Adjusted EPS rose to $0.29 in Q4, while full-year adjusted EPS increased to $0.89. The company is well-positioned as a critical partner in fighting diseases, including COVID-19.
Avantor, Inc. (NYSE: AVTR) has declared a quarterly cash dividend of $0.78 per share for its 6.250% Series A Mandatory Convertible Preferred Stock, representing a yield of 1.560%. This dividend will be payable on February 15, 2021 to shareholders on record as of February 1, 2021. The company emphasizes its commitment to enhancing shareholder value while maintaining a strong global presence in the life sciences and advanced materials sectors.
Avantor, a global provider of mission-critical products and services, will announce its fourth quarter and full year 2020 financial results after the market closes on February 3, 2021. A conference call to discuss these results will be held at 5:00 p.m. ET on the same day. Participants can join via phone or through a live webcast on the company's website. Avantor serves more than 225,000 customer locations globally, operating in key industries such as biopharma and healthcare.
Avantor (NYSE: AVTR) announced preliminary unaudited revenues for Q4 2020, estimating approximately $1.79B, reflecting an organic revenue growth of ~15%. The free cash flow is estimated at over $270M, significantly higher than $74.9M in Q4 2019. The results, to be finalized soon, align with the company's ongoing performance in life sciences and advanced materials. Management will present 2021 revenue expectations at the J.P. Morgan Healthcare Conference. Notably, these preliminary results are unaudited and may change upon final review.
Avantor (NYSE: AVTR) has announced a global initiative to support communities amid the COVID-19 pandemic. The company is donating over 1.5 million surgical masks and thermometers to schools in Mumbai and Delhi. Additionally, Avantor Foundation has granted nearly $350,000 to various organizations focusing on healthcare and STEM education. These efforts align with Avantor's mission to promote science for goodness and enhance patient outcomes through educational support and healthcare improvements.
Avantor, a leading provider of mission-critical products and services, will participate in the 39th Annual J.P. Morgan Healthcare Conference on January 11, 2021. CEO Michael Stubblefield will represent the company in a segment starting at approximately 9:10 a.m. Eastern Time. Investors can access a live webcast on Avantor's investor relations website, which will be available for replay until January 31, 2021.
With a global reach, Avantor serves over 225,000 customer locations in more than 180 countries, supporting critical research and development activities.
Avantor (NYSE: AVTR) will participate in the Evercore ISI 3rd Annual HealthCONx Virtual Conference on December 2, 2020. The event will feature a segment with Michael Stubblefield, President and CEO, starting at approximately 2:40 p.m. ET. Investors can access the live webcast via Avantor's investor relations website, and it will be available for replay until December 31, 2020. Avantor is a global leader in providing mission-critical products and services to various industries, supporting over 225,000 customer locations worldwide.
Avantor, Inc. (NYSE: AVTR) has launched a new biorepository and sample archiving facility in Frankfurt, Germany, enhancing access to samples within 24 hours for researchers. This facility is crucial for the growing demand for clinical trials, especially during the COVID-19 pandemic. Avantor boasts a 40-year heritage in biorepository services, having stored over 100 million research assets without failure. The facility has earned DGNB 'Gold' certification for sustainable construction, underscoring Avantor's commitment to ecological and economic responsibility.